Strand, S. H., Rivero-Gutierrez, B., Houlahan, K., Seoane Fernández, J. A., King, L. M., & Risom, T. (2022). Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.
Citación estilo ChicagoStrand, Siri H., Belen Rivero-Gutierrez, Kathleen Houlahan, Jose Antonio Seoane Fernández, Lorraine M. King, y Tyler Risom. Molecular Classification and Biomarkers of Clinical Outcome in Breast Ductal Carcinoma in Situ: Analysis of TBCRC 038 and RAHBT Cohorts. 2022.
Cita MLAStrand, Siri H., et al. Molecular Classification and Biomarkers of Clinical Outcome in Breast Ductal Carcinoma in Situ: Analysis of TBCRC 038 and RAHBT Cohorts. 2022.
Precaución: Estas citas no son 100% exactas.